Literature DB >> 19478537

alpha-Crystallin downregulates the expression of TNF-alpha and iNOS by activated rat retinal microglia in vitro and in vivo.

Nan Wu1, Yan-Hua Wang, Hai-Sheng Zhao, Dong-Ning Liu, Xi Ying, Zheng-Qin Yin, Yi Wang.   

Abstract

PURPOSE: Inhibition of microglial activation has become an important strategy to attenuate neurotoxic damage to the central nervous system. We evaluated the effects of alpha-crystallin on the production of cytokines in lipopolysaccharides (LPS) and optic nerve injury-activated retinal microglia.
METHODS: Microglia were collected from retinas of newborn rats, cultured and treated with LPS in vitro. Microglia were also activated by an optic nerve crush in vivo. Pretreatments with and without alpha-crystallin were performed in cultured cells, and by intravitreal injection in adult rats. Expression of tumor necrosis factor-alpha (TNF-alpha), nitric oxide (NO) and inducible NOS synthase (iNOS) were measured by RT-PCR, ELISA, Western blot and the nitrate reductase method.
RESULTS: Activated microglia significantly upregulated TNF-alpha and iNOS mRNA expression and protein production in vitro. An optic nerve crush also increased expression of retinal iNOS and TNF-alpha protein. Treatment with alpha-crystallin in vitro and in vivo downregulated their expression.
CONCLUSION: The protective effect of alpha-crystallin may be due to its effect on microglia via a downregulation in the expression and release of 2 key immune regulatory and inflammatory molecules: TNF-alpha and iNOS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19478537     DOI: 10.1159/000219681

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  13 in total

Review 1.  Novel roles for α-crystallins in retinal function and disease.

Authors:  Ram Kannan; Parameswaran G Sreekumar; David R Hinton
Journal:  Prog Retin Eye Res       Date:  2012-06-18       Impact factor: 21.198

2.  Crystallins and neuroinflammation: The glial side of the story.

Authors:  Jennifer E Dulle; Patrice E Fort
Journal:  Biochim Biophys Acta       Date:  2015-06-03

Review 3.  Heat shock proteins in the retina: Focus on HSP70 and alpha crystallins in ganglion cell survival.

Authors:  Natik Piri; Jacky M K Kwong; Lei Gu; Joseph Caprioli
Journal:  Prog Retin Eye Res       Date:  2016-03-24       Impact factor: 21.198

Review 4.  Targets of Neuroprotection in Glaucoma.

Authors:  Shaoqing He; Dorota L Stankowska; Dorette Z Ellis; Raghu R Krishnamoorthy; Thomas Yorio
Journal:  J Ocul Pharmacol Ther       Date:  2017-08-18       Impact factor: 2.671

5.  Computational analysis of tissue-specific gene networks: application to murine retinal functional studies.

Authors:  Jianfei Hu; Jun Wan; Laszlo Hackler; Donald J Zack; Jiang Qian
Journal:  Bioinformatics       Date:  2010-07-08       Impact factor: 6.937

Review 6.  New focus on alpha-crystallins in retinal neurodegenerative diseases.

Authors:  Patrice E Fort; Kirsten J Lampi
Journal:  Exp Eye Res       Date:  2010-11-27       Impact factor: 3.467

7.  Promotion of axon regeneration and inhibition of astrocyte activation by alpha A-crystallin on crushed optic nerve.

Authors:  Wei-Yang Shao; Xiao Liu; Xian-Liang Gu; Xi Ying; Nan Wu; Hai-Wei Xu; Yi Wang
Journal:  Int J Ophthalmol       Date:  2016-07-18       Impact factor: 1.779

8.  Maternal viral infection causes global alterations in porcine fetal microglia.

Authors:  Adrienne M Antonson; Marcus A Lawson; Megan P Caputo; Stephanie M Matt; Brian J Leyshon; Rodney W Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-16       Impact factor: 11.205

9.  Cloning of crystallin from orange-spotted grouper and characterization of its activity as potential protective agent.

Authors:  Young-Mao Chen; Cham-En Kuo; Chun-Mao Lin; Pei-Shiuan Shie; Tzong-Yueh Chen
Journal:  Results Immunol       Date:  2011-09-09

10.  Effects of maternal immune activation on gene expression patterns in the fetal brain.

Authors:  K A Garbett; E Y Hsiao; S Kálmán; P H Patterson; K Mirnics
Journal:  Transl Psychiatry       Date:  2012-04-03       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.